江西新赣江药业股份有限公司成立于2004年4月，位于江西省吉安市吉州区云章路36号，占地面积9.8万平方米，建筑面积4.8万平方米。
2023年2月在北京证券交易所挂牌上市（证券简称：新赣江，证券代码：920367），公司注册资金7082.125万元，是一家集化学原料药、化学药品制剂及中成药的研发、生产与销售为一体的国家高新技术企业、省级民营企业、省级技术中心企业。
公司自成立以来，一直将“质量为纲，信誉为本，开拓进取，务实创新”作为本公司的企业文化理念。公司主打品种主要包括化学药品原料药，化学药品制剂及中成药三大类。产品涵盖葡萄糖酸盐系列原料药，感冒类用药，心脑血管类用药，维生素类等领域。主导产品原料药葡萄糖酸钙、葡萄糖酸亚铁、葡萄糖酸锌;成品药为复方银翘氨敏胶囊、心脑康胶囊、地仲强骨胶囊、维生素c咀嚼片、感冒灵胶囊等，市场份额位居行业前列。
在政府和药监部门的大力支持和帮扶下，公司不断壮大发展，中药品种从无到有，从有到大。公司将立足国内，放眼世界，面对新的机遇和挑战，江西新赣江药业股份有限公司将不懈追求，为人类健康和祖国医药事业健康发展做出应有的贡献。
Profile of Jiangxi Xinganjiang Pharmaceutical Co., Ltd.
Jiangxi Xinganjiang Pharmaceutical Co., Ltd. was founded on April 2004 with its headquarter at No. 36 Yunzhang Road, Jizhou District, Ji'an City, Jiangxi Province. The company has a coverage of 98,000 m² with a total building area of 48,000 m².
The company is quoted on the Beijing Stock Exchange (Stock Abbreviation: Xinganjiang, Stock Code: 920367) in February 2023. It is a National High-tech Enterprise, a Provincial Private Enterprise and a Provincial Technology Center Enterprise with registered capital of 70.82125 million RMB. The Company has three business lines: research and development (R&D), production and sales of active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese patent medicines.
From its early beginnings the company has maintained its corporate culture and philosophy: Quality as the Cornerstone, Reputation as the Basis, Pioneering Progress, Pragmatism, Innovation.
Main Product Categories
The company's main products can be divided into three categories: active pharmaceutical ingredients (APIs); chemical drug preparations; and traditional Chinese patent medicines. It has a diverse portfolio that includes APFs in the gluconate series, cold medications, cardiovascular and cerebrovascular drugs, vitamins and other areas.
Top APIs: Calcium Gluconate, Ferrous Gluconate and Zinc Gluconate.
Leading Finished Medicines: Compound Yinquiao Aminomin Capsules, Xinnaokang Capsules, Dizhong Qianggu Capsules, Vitamin C Chewable Tablets and Ganmaoling Capsules.
These products have some of the highest market shares in the industry.
Under the strong support and assistance of the government and medical regulatory authorities, the company has steadily developed and expanded, and the traditional Chinese medicine product line has been built up to become a pillar of the company. Facing new opportunities and challenges, Jiangxi Xinanjiang Pharmaceutical Co., Ltd. will base itself domestically while keeping a global perspective, making continuous pursuits to contribute to human health and the healthy development of the nation's pharmaceutical industry.
赣公网安备36080202000500号
